Member Info for Darwen68

I doubt you'll get an definitive answer on the time frame for a clinical and longitudinal study.
It is akin to " how long a piece if string" - they can take weeks/months/years and decades.
They will need to evidence effectiveness and correlation against other methodology,measurement range,accuracy and precision.
A lot if this is already known (to those in the know!!)but has to be reproduced outside of the research lab to the relevant governing medical bodies and to any interested business parties.
Omicron was always going to cause some delay as they would need to ascertain it can be detected by the system.
Due to the nature of the virus and any business model ,I would assume it would not be viable for studies to be too lengthy,so weeks to months for me.

Manutdbo12
Don't know if you got the thread right,apologise if you had.
They are not looking at printer/razor manufacturers for development,but their sales methods.
Printer companies will give the printer away for free/nominal costs on the basis of repeat orders for the ink cartridges.
Razor companies give full handled razors away to then supply just the blades for further ongoing use.

The low cost of production is great and intriguing, as it gives whoever is in charge to offer varying deals to supply with or without cartridges.
Very common to give these "point of care testing" systems away for free on a reagent rental basis to high usage customers.
Other customers can buy the unit outright and then pay per cartridge on top.
Other revenue can be attained by offering a support system for troubleshooting and servicing.
Along with the other examples given it can also be likened to mobile phone sales ie contract,pay as you go and sim only.

Think share price went from -20% to -17% last I looked.
Sharkie will be claiming an RNS speeding ticket could be on its way.

It is not an unnecessary RNS,the silence had been defeaning from the board and there was much we deserved to know about developments from a the trimmed down company.
Following a fall in share price akin to a death from a thousands cuts we then then get confirmation in the RNS that we are invested in Flimflam - not what we wanted to know but least we now do.
Fusionboy was right that we could not supply masks in any notable volume,they can cannot put any more meat on the development of filters and they still entice us with the mysterious eight new sectors they would like to enter.
I imagine their R&D to be a couple of 8 year olds,a colouring book and crayons and a vivid imagination.

They want to look at acquisitions,they want to look at state of the art buildings - with four million pounds in the bank how much confidence do they inspire to use it wisely?
Can't see any new news coming soon,certainly nothing transformational - its a classic AIM share company.
I'm in !!

Now we know what Mark has been up to for the past three months - weaving the masks himself on a spinning loom.
I hope the above mentioned rumpellstiltskin is part of the key personnel he has head hunted for the increased production.
It's grim ( or should that be grimm).

Nanosynth have been thinking of venturing out into the "turkey and stuffing" market,but have decided its the wrong time of year to capitalise on such.

Kainos (again).
It is having a Turkish bath and I see you align yourself with alreadyinuse comments that it will wane into the background and governments have to get on with it because its the economy economy economy.

We focus on the immediate and rarely talk Long covid and its potential to debilitate. Spanish flu pandemic killed 50 million and infected a third of the worlds population,granted there was no vaccine,but the world was also not as travel interlinked as today - it could also be argued that we don't have a global vaccine either,we are just lucky.
Following spanish flu,the following decade saw unprecedented increase in neurological conditions of parkinsons,encephalitis and occular disturbances.What we will see in years/ decades is unclear but maybe the "healthy youngsters" will survive the virus but will just have to live with glued up kidneys,lungs and brains.

Kainos
Nobody is in the position to be unconcerned about the virus on a basis of good health/age.Some people are not as healthy as they think they are - maybe they are just undiagnosed and unaware.Also people have died and will die of this with no comobidities as it can simply overwhelm the bodies immune system (cytokine storm).
Then we have to consider this latest variant with the amount of mutations we may find it to be almost a different disease with at least 100 day start before we can counteract with vaccine updates - and then there's the ones around the corner.

Kainos.
I understand your premise.
If Mark Duffin can't use this opportunity to inform on updates on indian orders or feedback from the P4E nhs,if he can't give on update on tech in relation to filters or all the other "mysterious" applications then he/nanosynth will never get any traction.
I agree you can't just make stuff up but surely surely surely some direction/ideas have been formulated in the last 3 months.

I agree we had a TB debacle but at the moment I think we are near an MD debacle.

If Mark Duffin can't find an angle for an RNS or press release following the news events of the last couple of days there is little hope for him.
I would fall short in saying,I doubt we want Dr Cave to release a " I told you we were going to need a bigger boat" on twitter.

Think the worry is the number of mutations on the spike protein from the original delta.
32 mutations could render the virus unrecognisable by the bodies immune system and also too different for a vaccine cover - especially mRNA Pfizer and moderna type.
Granted small numbers at the moment,though we know the original delta variant was a step change in infection transmission.This new variant has been found in South Africa and Hong Kong where travel to and from is common.
Remember covid started with just the one person from at the time a little known place Wuhan.

Kainos.
They have set their stall out against three tough nuts to crack.The alzheimers trials were disappointing so hope for better to come elsewhere.
Bladder cancer is notoriously difficult to detect jn early onset and sepsis screening is quite a convoluted algorithm of patient presentation and blood work,and so any developments which produce more defined results would be a huge step change in diagnosis.
The introduction to being made routine within the medical setting will not happen overnight and would probably need the big pharma companies to upscale - certainly in relation to sepsis.
The flu vaccine this year is a bit scattergun,It is more of a ****tail with a couple of influenza A's and a couple of influenza B's.The population is not used to flu and bad colds after little winter flu rate last year and this winter people will suffer due to a reduced flu immunity and psychologically feeling worse because they aren't used to bad colds.
One concern I have is we were told " the paint was nearly dry on test results" and then it would seem they put another coat on - delays delays.

Here's to better sepsis, bladder,covid and flu detection.

kainos.
Just to bring you up to speed - covid kills.

It's not only just IMO,but also in in many many others.

It's been about year since Dr Cave laid his bigger boat quote on people.
It would seem Noah took up to 120 years to build his ark - bear in mind he was nearly 600 years old.

So who knows when the CEO will eventually update us but patience could be key and the results life saving.

Thank-you DrMicho.
This is why people should think twice about the AIM market and this type of forum.
The combination is like the wild west.There are so many negatives people have to overcome shorting,pump and dumps,death spiral funding,CEO's and management who are at this level for a reason.
Most money gained on this market is done through share price spikes,either by a manipulated rumour which snowballs due to FOMO and every now and again a breakthrough in technology or find.
Unitedguy et al are on most boards whenever any movement or interest develops. - Any investor who is not financially secure should not entertain this arena ,and will either have to be very lucky or will alas suffer.

From where I sit watching the unitedguy v sharkie game you are getting a tanking.
Unitedguy has more traction as he only has to repeat the same old,same old no news,no confirmations.You rattle on about biscuits.
If you are in the game to influence others to buy or sell for share price movement then I know who is winning.
I don't think it matters if he has "skin in the game" or not - you still have to counter his arguments/agenda better.
Lesson #2 - whatever that means.

Though I am no fan of him/her,unitedguy has nothing to apologise for.
It's like playing football against the Italians or argies,you won't like the tactics but it is often effective.
Unitedguy has the upper hand cos it's easy to seed doubt with so little jnformation/updates in the domain.
The so called rampers have nothing to ramp,apart from the hope of a boombastic rns,but it's been months since india/p4h and any CEO vision.
Aim shares are as much a lottery and anyone invested needs to know the risks before they invest.People talk about protecting "newbies" on this board, - only invest what can afford to lose ( it might be all of it,),and probably start somewhere other than the AIM market.

kainos.
do you write your drivel or do you have a cat that haphazardly walks on the keyboard and sits down.

Hello Kainos.
As I said,I was playing devils advocate and gave extremes.
Going back to the your original argument unless you legislate a mandatory vaccine policy,take up can only be improved by better health education,which you allude to in my other examples.
This winter is going to be cruel,the covid infection numbers look bleak even at this early stage,coupled with the population having a reduced immunity to seasonal flu.
But sorry you will not be able to charge non-vaccinated people for a hospital bed,it's better health education,combating crazy social media and people seeing a stark reality.
We'll have to agree to disagree.